1.18
price up icon0.85%   0.01
after-market Dopo l'orario di chiusura: 1.14 -0.04 -3.39%
loading

Oncolytics Biotech Inc Borsa (ONCY) Ultime notizie

pulisher
05:14 AM

Oncolytics Biotech files for common stock offering of $50 millionSEC filing - MarketScreener

05:14 AM
pulisher
11:47 AM

Published on: 2025-10-17 10:47:13 - newser.com

11:47 AM
pulisher
11:42 AM

Will earnings trigger a reversal in Oncolytics Biotech Inc.July 2025 Decliners & Advanced Technical Signal Analysis - newser.com

11:42 AM
pulisher
12:36 PM

Published on: 2025-10-16 23:36:43 - newser.com

12:36 PM
pulisher
Oct 15, 2025

Comparing Oncolytics Biotech Inc. in custom built stock radarsJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How Oncolytics Biotech Inc. stock trades before earningsChart Signals & Proven Capital Preservation Tips - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Relative strength of Oncolytics Biotech Inc. in sector analysisWeekly Risk Report & Weekly Stock Performance Updates - newser.com

Oct 15, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 09:59:15 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 08:31:55 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Oncolytics Biotech Inc. stock overvalued by current metricsMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 07:15:35 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 13, 2025
pulisher
Oct 10, 2025

Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy - TipRanks

Oct 10, 2025
pulisher
Oct 10, 2025

Understanding Oncolytics Biotech Inc.’s price movementMarket Growth Summary & Weekly Breakout Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Oncolytics Biotech's (ONCY) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Is Oncolytics Biotech Inc. reversing from oversold territoryGold Moves & Real-Time Stock Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Oncolytics Biotech (NASDAQ:ONCY) Trading Down 3.1%Should You Sell? - MarketBeat

Oct 10, 2025
pulisher
Oct 06, 2025

Oncolytic Virus Therapy Market Size to Hit USD 11.13 Billion by 2034 - Precedence Research

Oct 06, 2025
pulisher
Oct 06, 2025

Volatility clustering patterns for Oncolytics Biotech Inc.Market Sentiment Review & Weekly Consistent Profit Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Oncolytics Biotech Inc. forming a bottoming baseJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Oncolytics Biotech Inc. stock positioned for long term growthTrade Risk Summary & Safe Entry Momentum Tips - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 07:12:20 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using RSI to spot recovery in Oncolytics Biotech Inc.July 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Candlestick signals on Oncolytics Biotech Inc. stock todayMarket Movement Recap & Community Driven Trade Alerts - newser.com

Oct 03, 2025
pulisher
Sep 29, 2025

Oncolytics Biotech unveils design for pancreatic cancer registration trial By Investing.com - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

Is Oncolytics Biotech Inc a good long term investmentTrading Volume Trends & Access Our Free Weekly Investment Letter - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

What Makes Vision Corporation Limited Stand Out Among CompetitorsDouble Top/Bottom Patterns & Big Gains Small Budget - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Stocks in play: Oncolytics Biotech Inc. - The Globe and Mail

Sep 29, 2025
pulisher
Sep 29, 2025

Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design - TipRanks

Sep 29, 2025
pulisher
Sep 29, 2025

Oncolytics Biotech announces update for potential first-line pancreatic cancer registration study - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Oncolytics Biotech® Announces Update for Potential First-Line Pa - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Stocks In Play: Oncolytics Biotech Inc - Barchart.com

Sep 29, 2025
pulisher
Sep 29, 2025

Oncolytics Biotech unveils design for pancreatic cancer registration trial - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study - PR Newswire

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Oncolytics Biotech Inc stockMean Reversion Trades & Free Daily Top Stock Picks for All Investors - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Oncolytics Biotech Inc stock priceReal-Time Stock Alerts & See Risk Factors Before Making Any Move - earlytimes.in

Sep 28, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):